Hyman Lab

Overview

Dr. Hyman directs the Alzheimer’s disease research unit at the MassGeneral Institute for Neurodegenerative Disease with the goal of understanding the neuropathophysiologic and genetic factors that underlie dementia. His laboratory studies the anatomical and molecular basis of dementia in Alzheimer’s disease, and dementia with Lewy bodies.

Dr. Hyman’s research includes a collaborative of several labs working on different aspects of neurodegenerative disease and dementia. The following principal investigators have research labs and collaborate with Dr. Hyman’s lab.

Principal Investigator

Bradley T. Hyman, MD, PhD

• John B. Penney, Jr. Professor of Neurology 
  Harvard Medical School
• Associate in Neurology,
  Massachusetts General Hospital
• Director,
  Massachusetts Alzheimer's Disease Research Center

Affiliated Principal Investigators

• Mark W. Albers, MD, PhD - Olfactory biology and neruodegeneration
• Brian Backsai, PhD - Multiphoton imaging, functional studies of neural systems
• Oksana Berezovska, PhD - Biology of presenilin and gamma secretase
• Matthew Frosch, MD, PhD - Cerebral Amyloid Angiopathy, Alzheimer's, Parkinson's diseases 
• Teresa Gomez-Isla, MD, PhD - Neurobiology of normal aging; studies of GSK3b, animal models of Alzheimer’s
• Brad Hyman, MD, PhD  - Clinical pathological correlations and animal models of Alzheimer’s and Lewy body diseases; in vivo imaging; apoE neurobiology  

Laboratory Staff - includes all lab members of principal investigator labs

• Arbel, Michal, PhD
• Arimon, Muriel, PhD
• Barroeta-Espar, Isabel, MD
• Cagsal-Getkin, Ozge
• Cao, Luxiang, PhD
• Costantino, Isabel
• Dashkoff, Jonathan, MD/PhD
• Fan, Zhanyun
• Galea, Elena, PhD Sabbatical from Spain
• Hawkes, Jonathan
• Herskovits, Zara, MD, PhD
• Hori, Yukiko, PhD
• Hou, Steven ()
• Hudry, Eloise, PhD
• Kastanenka, Ksenia, PhD
• Kuzuya, Akira, MD, PhD
• Laffey, Gala Guerard
• Lee, Allyson
• Liu, Andy
• Marquie-Sayagues, Marta, MD
• Neville, Kevin
• Nicholls, Samantha, PhD
• Patel, Nehal
• Perez-Nievas Gomez, Beatriz, PhD
• Polydoro, Manuela, PhD
• Pooler, Amy, PhD
• Rice, Wendy
• Rodriguez, Steven, PhD
• Rudinskiy, Nikita, PhD
• Saqran, Lubna,
• Shakerdge, Naomi 
• Takeda, Shuko, MD, PhD
• Vanderburg, Chuck, PhD
• Wang, Xueying
• Wegmann, Susanne, PhD
• William, Chris, MD, PhD

Updated 9/12/2013

Read about and apply for residency, fellowship and observership programs at http://www.massgeneral.org/neurology/education/.

All applicants should register with the Mass General Careers Web site at http://www.massgeneral.org/careers/viewall.aspx. Request a list of current open positions at mghneurologyjobs@partners.org.

View All PubMed Publications

1. Hyman BT, Yuan J. Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology. Nat Rev Neurosci. 2012; 13(6):395-406. View in: PubMed
2. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kövari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012 May; 71(5):362-81. View in: PubMed
3. Wu HY, Hudry E, Hashimoto T, Uemura K, Fan ZY, Berezovska O, Grosskreutz CL, Bacskai BJ, Hyman BT. Distinct Dendritic Spine and Nuclear Phases of Calcineurin Activation after Exposure to Amyloid-ß Revealed by a Novel Fluorescence Resonance Energy Transfer Assay. J Neurosci. 2012 Apr 11; 32(15):5298-309. View in: PubMed
4. Pankratz N, Beecham GW, Destefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T. Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2. Ann Neurol. 2012 Mar; 71(3):370-84. View in: PubMed
5. Hudry E, Wu HY, Arbel-Ornath M, Hashimoto T, Matsouaka R, Fan Z, Spires-Jones TL, Betensky RA, Bacskai BJ, Hyman BT. Inhibition of the NFAT pathway alleviates amyloid Beta neurotoxicity in a mouse model of Alzheimer's disease. J Neurosci. 2012 Feb 29; 32(9):3176-92. View in: PubMed